Kaya Holdings (KAYS) Notes Payables (2013 - 2025)

Kaya Holdings (KAYS) recorded quarterly Notes Payables of $59312.0 in Q3 2025, down 75.54% quarter-over-quarter from $242500.0 in Q2 2025, and up 536.94% on a YoY basis from $9312.0 in Q3 2024.

Kaya Holdings (KAYS) Notes Payables (2013 - 2025) Analysis & Trends

Kaya Holdings' Notes Payables history runs 13 years deep, the most recent figure standing at $59312.0 for Q3 2025.

  • In Q3 2025, Notes Payables rose 536.94% year-over-year to $59312.0; the TTM figure through Sep 2025 stood at $59312.0 (up 536.94% YoY), while the FY2024 annual figure was $9312.0, down 92.51% from the prior year.
  • Notes Payables was $59312.0 for Q3 2025 at Kaya Holdings, down from $242500.0 in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $6.7 million in Q1 2021 to a low of $9312.0 in Q4 2021.
  • Historically, Notes Payables has averaged $788237.3 across 5 years, with a median of $17156.0 in 2021.
  • The sharpest annual moves came in 2021 and 2022: Notes Payables jumped 2585.72% in 2021, then sank 99.86% in 2022.
  • A 5-year view of Notes Payables shows it stood at $9312.0 in 2021, then changed by 0.0% to $9312.0 in 2022, then surged by 1234.97% to $124312.0 in 2023, then slumped by 92.51% to $9312.0 in 2024, then surged by 536.94% to $59312.0 in 2025.
  • The last three Notes Payables figures came in at $59312.0 (Q3 2025), $242500.0 (Q2 2025), and $70920.0 (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn
10 Kaya Holdings - - 5,370.00

Historic Data

Download Data
DateValue
Sep 30, 2025 59,312.00
Jun 30, 2025 242,500.00
Mar 31, 2025 70,920.00
Dec 31, 2024 9,312.00
Sep 30, 2024 9,312.00
Jun 30, 2024 9,312.00
Mar 31, 2024 9,312.00
Dec 31, 2023 124,312.00
Sep 30, 2023 25,000.00
Jun 30, 2023 25,000.00
Mar 31, 2023 9,312.00
Dec 31, 2022 9,312.00
Sep 30, 2022 93,340.00
Jun 30, 2022 9,312.00
Mar 31, 2022 9,312.00
Dec 31, 2021 9,312.00
Jun 30, 2021 6.71 Mn
Mar 31, 2021 6.75 Mn
Dec 31, 2020 363,243.00
Sep 30, 2020 250,000.00